Openbookopenbook
Equity
Global Cord Blood Corporation(CORBF)
USD --+0.00%
Reward63Moderate
Risk16Low
📊75%Data
Strong 40% profit margin
CORBF
+0.0 · +0.00%
USD · OTCMKTS
Global Cord Blood Corporation | Healthcare
Quality Compounder
Market Cap:140.61M
ℹ️
Reward Rating
63
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
16
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CORBF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: ¥15.00.

What is Global Cord Blood Corporation?

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China.

CORBF · Verdict

Solid reward · low risk

CORBF scores well on balance sheet and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

CORBF · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet99/100

    Interest covered 15.8×

  • Cash flow89/100

    48% free-cash-flow margin

  • Profitability85/100

    40% net margin · 11% ROE

  • Valuation78/100

    Above average

  • Volatility75/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Global Cord Blood Corporation?

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company is listed on the OTCMKTS in USA, operating in the Healthcare sector, with a market capitalisation of 140.61M, and a P/E ratio of 3.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap140.61M
P/E Ratio3.3871
Dividend YieldN/A
52 Week High1.75
52 Week Low0.2
Last AnnualMarch
IPO Date5/9/2007
IncorporatedUSA
Shares Outstanding134M
No. of Employees1,202
IndustryDiagnostics & Research
ExchangeOTCMKTS
Beta-0.806
CurrencyUSD · Reports in CNY
Websitewww.globalcordbloodcorp.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.